XML 20 R37.htm IDEA: XBRL DOCUMENT v3.20.1
15. Parent Company Financial Statements (Tables)
 12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Parent Balance Sheets
Assets   2019     2018  
Current assets            
Cash and cash equivalents   $ -     $ -  
Receivables due from subsidiaries     -       5,057  
Prepaid expenses     290       364  
Other current assets     29       -  
Total current assets     319       5,421  
                 
Investment in AE Advanced Products Keyes , Inc.     293       1,057  
Investment in Aemetis International, Inc.     3,638       -  
Total investments in Subsidiaries, net of advances     3,931       1,057  
                 
Property, plant and equipment, net     4       12  
Other assets     257       54  
Total Assets   $ 4,511     $ 6,544  
                 
Liabilities & stockholders' deficit                
Current liabilities                
Accounts payable   $ 5,097     $ 5,026  
Payables due to subsidiaries     3,176       -  
Mandatorily redeemable Series B convertible preferred     3,149       3,048  
GAFI -payables, net of SARs discount issuance costs     -       1,090  
SARs liability     -       1,132  
Other current liabilities     9,217       2,215  
Total current liabilities     20,639       12,511  
                 

 

Parent Company long term debt portion of secured notes, net of discount for issuance cost

 

            
Subsidiary obligation in excess of investment                
Investment in AE Advanced Fuels, Inc.     112,041       89,854  
Investment in Aemetis Americas, Inc     205       205  
Investment in Aemetis Biofuels, Inc.     2,738       2,738  
Investment in Aemetis Technologies, Inc.     4,234       4,030  
Investment in Aemetis Property Keyes, Inc.     564       432  
Investment in Biofuels Marketing, Inc.     349       349  
Investment in Aemetis International, Inc.     -       963  
Investment in Goodland Advanced Fuels, Inc.     8,501       -  
Investment in Aemetis Biogas LLC     9,612       6,304  
Total subsidiary obligation in excess of investment     138,244       104,875  
                 
Total long term liabilities     138,244       104,875  
                 
Stockholders' deficit                
Series B Preferred convertible stock     1       1  
Common stock     21       20  
Additional paid-in capital     86,852       85,917  
Accumulated deficit     (237,421 )     (193,204 )
Accumulated other comprehensive loss     (3,825 )     (3,576 )
Total stockholders' deficit     (154,372 )     (110,842 )
Total liabilities & stockholders' deficit   $ 4,511     $ 6,544  
Parent Statements of Operations and Comprehensive Loss
    2019     2018  
             
Equity in subsidiary losses   $ (21,745 )   $ (29,009 )
Selling, general and administrative expenses     6,673       8,742  
                 
Operating loss     (28,418 )     (37,751 )
                 
Other expense                
Interest expense     1,392       1,281  
Other (income) expense     5,899       (6,023 )
                 
 Loss before income taxes     (35,709 )     (33,009 )
                 
Income tax expense     7       7  
                 
Net loss     (35,716 )     (33,016 )
                 
Other comprehensive loss                
Foreign currency translation adjustment     (249 )     (672 )
Comprehensive loss   $ (35,965 )   $ (33,688 )
Parent Statements of Cash Flows
    2019     2018  
Operating activities:            
Net loss     (35,716 )     (33,016 )
Adjustments to reconcile net loss to net cash used in operating activities:                
                 
Stock-based compensation     774       981  
Stock issued for services     -       22  
SARs Amortization     800       477  
Depreciation     8       8  
Subsidiary portion of net losses     21,745       29,009  
Change in fair value of SARs liability     (82 )     (145 )
Changes in assets and liabilities:                
Prepaid expenses     74       (113 )
Accounts payable     71       1,459  
Accrued interest expense     1,184       209  
Other liabilities     5,891       275  
Other assets     (232 )     -  
Net cash used in operating activities     (5,483 )     (834 )
                 
Investing activities:                
Subsidiary advances, net     6,781       2,119  
Net cash provided by investing activities     6,781       2,119  
                 
Financing activities:                
Proceeds from borrowings under secured debt facilities     -       1,500  
Repayments of borrowings under secured debt facilities     (1,298 )     (2,814 )
Net cash used by financing activities     (1,298 )     (1,314 )
                 
Net decrease in cash and cash equivalents     -       (29 )
                 
Cash and cash equivalents at beginning of period     -       29  
Cash and cash equivalents at end of period   $ -     $ -  
                 
Supplemental disclosures of cash flow information, cash paid:                
Interest payments     -       -  
Income tax expense     8       7  
                 
Supplemental disclosures of cash flow information, non-cash transactions:                
                 
Fair value of warrants issued to subordinated debt holders     162       235  
Exercise of Stock Appreciation Rights added to GAFI debt     1,050       -  
Stock Appreciation Rights issued for GAFI Amendment No. 1     -       1,277  
Reclassification of GAFI Non-controlling interest     8,501       -